158 related articles for article (PubMed ID: 23051787)
21. Gary Pisano.
Pisano G
Nat Biotechnol; 2011 Mar; 29(3):183. PubMed ID: 21390002
[No Abstract] [Full Text] [Related]
22. Legal and social aspects of biotechnology in Poland.
Twardowski T
Acta Biochim Pol; 2005; 52(3):III-V. PubMed ID: 16475253
[No Abstract] [Full Text] [Related]
23. Stelios Papadopoulos.
Papadopoulos S
Nat Biotechnol; 2011 Mar; 29(3):184. PubMed ID: 21390003
[No Abstract] [Full Text] [Related]
24. Ahead of the pack.
Ledford H
Nature; 2009 May; 459(7244):286-7. PubMed ID: 19548328
[No Abstract] [Full Text] [Related]
25. Science at a crossroads.
Bonvillian WB
FASEB J; 2002 Jul; 16(9):915-21. PubMed ID: 12087052
[TBL] [Abstract][Full Text] [Related]
26. Berkeley dispute festers over biotech deal.
Dalton R
Nature; 1999 May; 399(6731):5. PubMed ID: 10331373
[No Abstract] [Full Text] [Related]
27. The technology trap.
Gewin V
Nature; 2005 Oct; 437(7061):948-9. PubMed ID: 16222269
[No Abstract] [Full Text] [Related]
28. Wage power in the life sciences.
Lawrence S
Nat Biotechnol; 2008 Jan; 26(1):14. PubMed ID: 18183005
[No Abstract] [Full Text] [Related]
29. Nontraditional publications and their effect on patentable inventions.
Garabedian TE
Nat Biotechnol; 2002 Apr; 20(4):401-2. PubMed ID: 11923849
[No Abstract] [Full Text] [Related]
30. Japan launches new life-science initiatives.
Triendl R
Nat Biotechnol; 2003 Mar; 21(3):218. PubMed ID: 12610556
[No Abstract] [Full Text] [Related]
31. Kiran Mazumdar-Shaw.
Jayaraman KS
Nat Biotechnol; 2005 Jan; 23(1):11. PubMed ID: 15637602
[No Abstract] [Full Text] [Related]
32. Real options for biotechnology valuation.
Harrison M; Lerer L
Nat Biotechnol; 2002 Mar; 20(3):223-4. PubMed ID: 11875412
[No Abstract] [Full Text] [Related]
33. Among the best.
Jayaraman KS
Nature; 2005 Jul; 436(7050):492-5. PubMed ID: 16049476
[No Abstract] [Full Text] [Related]
34. DPI delivers biotechnology superstore. Discovery Partners International.
Glaser V
Nat Biotechnol; 1998 Dec; 16(13):1302. PubMed ID: 9853596
[No Abstract] [Full Text] [Related]
35. Life sciences: all jazzed up.
Mascarelli A
Nature; 2012 Jun; 486(7403):429-31. PubMed ID: 22730564
[No Abstract] [Full Text] [Related]
36. Scientific workforce. Poor job market blunts impact of new master's programs.
Bhattacharjee Y
Science; 2003 Aug; 301(5634):752-3. PubMed ID: 12907772
[No Abstract] [Full Text] [Related]
37. Space-station cuts leave research in lurch.
Reichhardt T
Nature; 2001 Mar; 410(6827):399. PubMed ID: 11260673
[No Abstract] [Full Text] [Related]
38. The changing norms of the life sciences.
Shorett P; Rabinow P; Billings PR
Nat Biotechnol; 2003 Feb; 21(2):123-5. PubMed ID: 12560827
[No Abstract] [Full Text] [Related]
39. France seeks to tighten its control over life sciences.
Butler D
Nature; 1995 Mar; 374(6519):206. PubMed ID: 7885435
[No Abstract] [Full Text] [Related]
40. Innovation for life science innovators.
Cancer Discov; 2012 Dec; 2(12):OF1. PubMed ID: 23230190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
